Literature DB >> 8702448

Juvenile rheumatoid arthritis in Rochester, Minnesota 1960-1993. Is the epidemiology changing?

L S Peterson1, T Mason, A M Nelson, W M O'Fallon, S E Gabriel.   

Abstract

OBJECTIVE: To examine trends in the incidence and prevalence of juvenile rheumatoid arthritis (JRA) in Rochester, Minnesota, over 33 years.
METHODS: The diagnostic retrieval system of the Rochester Epidemiology Project was utilized to screen medical records of all Rochester residents with any potential diagnoses of JRA from 1978 to 1993 (based on the American College of Rheumatology 1977 revised criteria). In addition, all cases of JRA from our previously identified cohort from 1960-1979 were verified, and the 2 data sets were combined, resulting in an incidence cohort spanning 33 years (1960-1993).
RESULTS: Of the 1,240 medical records screened, we identified 65 cases of JRA diagnosed between 1960 and 1993 (48 females, 17 males). The average followup for cases was 12.7 years (range 0-34 years) for a total of 833 person-years of observation. A bimodal distribution of age at diagnosis was observed, with peaks between 0 and 4 years and 9 and 15 years. Seventy-two percent of patients had pauciarticular-onset, 17% had polyarticular-onset, and 11% had systemic-onset disease. Progression of pauciarticular to polyarticular disease occurred in 11% of the cases. The overall age- and sex-adjusted incidence rate was 11.7 per 100,000 population (95% confidence intervals 8.7, 14.8). The incidence rate per 100,000 population was 15.0, 14.1, and 7.8 for the time periods 1960-1969, 1970-1979, and 1980-1993, respectively (P = 0.024). A 3-year, centered, moving average, which was used to display time trends in incidence, suggested a cyclical pattern, with incidence peaks in 1967, 1975, and 1987.
CONCLUSION: An overall decrease in the incidence rate over the last decade was observed, most marked in the pauciarticular- and systemic-onset subtypes. This decrease, along with the observed cyclical pattern, suggest that environmental factors may influence disease frequency.

Entities:  

Mesh:

Year:  1996        PMID: 8702448     DOI: 10.1002/art.1780390817

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  24 in total

1.  Juvenile Idiopathic Arthritis in Olmsted County, Minnesota, 1960-2013.

Authors:  Megan L Krause; Cynthia S Crowson; C John Michet; Thomas Mason; Theresa Wampler Muskardin; Eric L Matteson
Journal:  Arthritis Rheumatol       Date:  2016-01       Impact factor: 10.995

2.  Evaluation and Treatment of Enthesitis-Related Arthritis.

Authors:  Pamela F Weiss
Journal:  Curr Med Lit Rheumatol       Date:  2013

Review 3.  The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases.

Authors:  Hilal Maradit Kremers; Elena Myasoedova; Cynthia S Crowson; Guergana Savova; Sherine E Gabriel; Eric L Matteson
Journal:  Rheumatology (Oxford)       Date:  2010-07-13       Impact factor: 7.580

4.  Incidence and prevalence of juvenile idiopathic arthritis among children in a managed care population, 1996-2009.

Authors:  Leslie R Harrold; Craig Salman; Stanford Shoor; Jeffrey R Curtis; Maryam M Asgari; Joel M Gelfand; Jashin J Wu; Lisa J Herrinton
Journal:  J Rheumatol       Date:  2013-04-15       Impact factor: 4.666

5.  Preventing tuberculosis in children receiving anti-TNF treatment.

Authors:  Nuray Aktay Ayaz; Erkan Demirkaya; Yelda Bilginer; Uğur Ozçelik; Nazan Cobanoğlu; Nural Kiper; Nesrin Besbas; Aysin Bakkaloğlu; Seza Ozen
Journal:  Clin Rheumatol       Date:  2010-04       Impact factor: 2.980

6.  An evaluation of the utility of routine laboratory monitoring of juvenile idiopathic arthritis (JIA) patients using non-steroidal anti-inflammatory drugs (NSAIDs): a retrospective review.

Authors:  Sheetal S Vora; Christine E Bengtson; Grant D Syverson; James J Nocton
Journal:  Pediatr Rheumatol Online J       Date:  2010-04-14       Impact factor: 3.054

7.  The effect of infliximab plus methotrexate on the modulation of inflammatory disease markers in juvenile idiopathic arthritis: analyses from a randomized, placebo-controlled trial.

Authors:  Sudha Visvanathan; Carrie Wagner; Joseph C Marini; Daniel J Lovell; Alberto Martini; Ross Petty; Ruben Cuttica; Patricia Woo; Graciela Espada; Marco Gattorno; Maria T Apaz; Eileen Baildam; Anders Fasth; Valeria Gerloni; Pekka Lahdenne; Pierre Quartier; Rotraud Saurenmann; Suzanne Travers; Alan Mendelsohn; Stephen Xu; Edward H Giannini; Nicolino Ruperto
Journal:  Pediatr Rheumatol Online J       Date:  2010-09-07       Impact factor: 3.054

8.  Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis.

Authors:  Marloes W Heijstek; Gecilmara C S Pileggi; Evelien Zonneveld-Huijssoon; Wineke Armbrust; Esther P A H Hoppenreijs; Cuno S P M Uiterwaal; Wietse Kuis; Nico M Wulffraat
Journal:  Ann Rheum Dis       Date:  2007-02-06       Impact factor: 19.103

Review 9.  Juvenile idiopathic arthritis - the role of imaging from a rheumatologist's perspective.

Authors:  Clara Malattia; Nikolay Tzaribachev; J Merlijn van den Berg; Silvia Magni-Manzoni
Journal:  Pediatr Radiol       Date:  2018-05-08

Review 10.  Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.

Authors:  Sherine E Gabriel; Kaleb Michaud
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.